19 October-30 November 2020
The 51st Union World Conference On Lung Health
REGISTER NOW

Sessions

keyboard_arrow_down Show filters keyboard_arrow_up Hide filters
  • All Tracks
  • Community Connect
  • Channel 1
  • Channel 2
  • Channel 3
  • Channel 4
  • Channel 5
  • Channel 6
  • Channel 7
  • E-posters
  • Workshops
Channel 1
Opening Ceremony
event_note Tuesday, 20 Oct 2020
query_builder 14:00 - 15:00 | Event time (GMT+2)
query_builder 14:00 - 15:00 | Your time (GMT)
place Online Session/Virtual
card_travel Opening Ceremony
mic English
Opening Ceremony
*Please scroll down for more information*
Opening Ceremony: Marking The Union's Centennial Year
20 October 2020              2PM-3PM CEST
 
On 20 October 1920, representatives from 31 countries, recognising that a global health crisis – tuberculosis – could not be defeated without international collaboration and knowledge sharing, came together and founded The Union. One hundred years later, as the world struggles to confront a new infectious respiratory disease – COVID-19 – our founders’ vision remains as relevant as ever.

As The Union turns a century old, we also embark upon the first ever virtual Union World Conference. The opening ceremony will reflect on the journey so far and the distance left to travel.
 
We will hear from:
 - Her Imperial Highness Crown Princess Akishino of Japan
- President Bill Clinton
- World Health Organization Director-General Dr Tedros Adhanom Ghebreyesus
- Yvonne Chaka Chaka, singer, entrepreneur, Global Health Advocate and humanitarian
- Divya Sojan, TB survivor and nurse
- Shannon Hader, Deputy Executive Director United Nations Programme on HIV/AIDS (UNAIDS)
- Katherine Maher, Chief Executive of the Wikimedia Foundation (Interviewed by Noam Cohen, WIRED)
- Claire Forlani, UK Film and TV Actress, and The Union’s TB Ambassador
- Dr Tamaryn Green, TB Survivor, Medical Doctor, Miss South Africa 2018
 
President of The Union, Professor Guy Marks, The Union’s Executive Director, José Luis Castro, and Dr Keren Middelkoop, Chair Coordinating Committee of Scientific Activities will also speak.

Please join our opening ceremony and we wish you an inspiring virtual Union World Conference.

Channel 4
MTE-02-Meet the expert session: Adult and Child Lung Health
event_note Wednesday, 21 Oct 2020
query_builder 9:45 - 10:45 | Event time (GMT+2)
query_builder 9:45 - 10:45 | Your time (GMT)
place Online Session/Virtual
card_travel Meet the expert session
mic English
MTE-02-Meet the expert session: Adult and Child Lung Health
*Please scroll down for more information*
TB vaccine for children

Please note that the number of participants is limited for this session.

Moderators
Elisa Nemes
Associate Professor
South African Tuberculosis Vaccine Initiative (SATVI), University of Cape Town
star star star star star
Agnès Djengue
Conference Programme Coordinator
The Union
star star star star star
Channel 3
MTE-01-Meet the expert session: civil society
event_note Wednesday, 21 Oct 2020
query_builder 9:45 - 10:45 | Event time (GMT+2)
query_builder 9:45 - 10:45 | Your time (GMT)
place Online Session/Virtual
card_travel Meet the expert session
mic English
MTE-01-Meet the expert session: civil society
*Please scroll down for more information*

Health advocacy for access to care

Alternative respond to Covid-19 by the Civil Society Organisations in South Africa

Please note that the number of participants is limited to 50 for this session.

Moderators
Audrey Pâquet
The Union
star star star star star
E-posters
EP10-Overcoming barriers in the contact cascade of care
event_note Wednesday, 21 Oct 2020
query_builder 10:00 - 11:00 | Event time (GMT+2)
query_builder 10:00 - 11:00 | Your time (GMT)
place Online Session/Virtual
card_travel E-poster session
mic English
EP10-Overcoming barriers in the contact cascade of care
*Please scroll down for more information*
These E-posters will be displayed from 10 am Central European Summer Time, on Wednesday 21 October for 24 hours.

EP10-187-21-A missed opportunity: active contact investigation of diagnosed TB patients in NigeriaPeople who have been in close contact with bacteriologically confirmed pulmonary tuberculosis (TB) patients constitute a high-risk group for developing TB disease. Active household contact investigation of index TB patients demonstrates a great opportunity to increase a diverse pool of human resources, capacity to diagnosis and to notify additional TB cases.
Sani Useni

EP10-188-21-Risk of developing active multidrug-resistant TB among contacts in Taiwan, 2016-2018Identifying at-risk contacts, who have been exposed to a multidrug-resistant tuberculosis (MDR-TB) index patient, to see if they develop active disease would help advancing prevention of MDR-TB in Taiwan. In addition, active follow-up and prioritising those household or IGRA-positive contacts for latent TB treatment may further decline the incidence of MDR-TB. 
Pin Hui Lee

EP10-189-21-Utility of interferon gamma/tumor necrosis factor alpha FluoroSpot assay in differentiation between active TB and latent TB infection: a pilot studyWe aimed to provide a highly sensitive and practical auxiliary method for tuberculosis (TB) differential diagnosis. In this abstract, we demonstrated the diagnostic accuracy of the interferon gamma/tumor necrosis factor alpha (IFN-γ/TNF-α ) FluoroSpot assay for differentiating active TB from latent TB infection. 
Ziyue Zhou

EP10-190-21-Results of management latent TB infection in Quang Nam province, Viet Nam, 2017-2018Results of the management of latent tuberculosis (TB) infection during the period of 2017-2018 in Quang Nam province, Viet Nam. Interventions have shown to be effective in increasing the ability to identify, screen TB and treat latent TB infection among household contacts of TB patients.
LV Vinh

EP10-192-21-Effectiveness of contact tracing intervention for improving TB case detection in NigeriaSystematic investigation of contacts of index TB cases for active disease has remained a priority active case finding strategy. Stakeholders for tuberculosis (TB) control need to apply the right strategy, job aid, tools and training for health workers to help standardise TB information and empower communities with the right TB knowledge
Chidubem Ogbudebe

EP10-193-21-Dilemma in contact investigation: to expand or notContact investigation as a part of Dutch tuberculosis (TB) policy aims for early case detection, treatment and prevention of TB transmission. Risk assessment forms a basic approach to the organisation of contact investigation.
Sophie Toumanian

EP10-194-21-Piloting a shortened regimen for the treatment of latent TB infection in two provinces of Viet NamIn 2019, Friends for International TB Relief, together with the Viet Nam National TB Programme, implemented community-based tuberculosis (TB) case finding campaigns with integrated latent TB infection testing and treatment using a shortened regimen in two provinces of Viet Nam. We herein describe the results of these activities.
Thuy Thu Thi Dong

EP10-195-21-Prevalence of latent TB infection and predictive factors among working-age population in urban and rural area of Northern Guangdong, China: a cross-sectional studyChina has one of the highest burdens of latent tuberculosis (TB) infection (LTBI). Studies, which mainly focused on high-risk population, observed LTBI prevalence ranging from 9% up to 70%. The goal of this study was to describe LTBI burden in the general population, especially in those of working age, and determine its associated factors.
Fangjing ZHOU

EP10-196-21-Impact of civil society advocacy on the introduction of TB LAM testing in PEPFAR-eligible countriesUptake of tuberculosis (TB) LAM testing in high TB and HIV burden countries has been limited despite a demonstrated mortality benefit among people with advanced HIV. We reviewed FY2018 and FY2019 PEPFAR country operational plans to evaluate the impact of advocacy on TB LAM uptake in PEPFAR-eligible countries.
David Branigan

Speakers
Thuy Thu Thi Dong
Friends for International TB Relief
star star star star star
Pin Hui Lee
Taiwan Centers for Disease Control
star star star star star
Ziyue Zhou
Peking Union Medical College
star star star star star
LV Vinh
Pham Ngoc Thach Hospital of Quang Nam
star star star star star
Chidubem Ogbudebe
KNCV Tuberculosis Foundation
star star star star star
Fangjing ZHOU
Center for Tuberculosis Control of Guangdong Province
star star star star star
E-posters
EP08-COVID-19 and TB: friends or foes?
event_note Wednesday, 21 Oct 2020
query_builder 10:00 - 11:00 | Event time (GMT+2)
query_builder 10:00 - 11:00 | Your time (GMT)
place Online Session/Virtual
card_travel E-poster session
mic English
EP08-COVID-19 and TB: friends or foes?
*Please scroll down for more information*
These E-posters will be displayed from 10 am Central European Summer Time, on Wednesday 21 October for 24 hours.

EP08-168-21-TB and Covid-19: Bangladesh perspective and challengesCovid-19 posed challenges in tuberculosis (TB) control in Bangladesh. During the first two months of the pandemic, a decrease in TB patients was reported. Patient-centred care was ensured by providing medicine to the patients and using telecommunication. Interim and long-term preparedness is required to resume enhanced momentum of TB control.
Mahfuza Rifat

EP08-169-21-The impact of Covid-19 on TB control in the Coast General Teaching and Referral Hospital, Mombasa County, KenyaKenya confirmed its first case of Covid-19 on 12 March 2020. In an effort to combat the pandemic Kenya, like the rest of the world, introduced some changes to its health service delivery. Being a country with a high tuberculosis (TB) burden, this had an impact on TB patients accessing care.
Cosmas Mwashumbe

EP08-170-21-Design and organisation of a temporary intensive care ward in response to the COVID-19 pandemicCOVID-19 placed a heavy burden on medical services. We designed and organised a temporary intensive care unit (ICU) ward within 48 hours. The space design, environmental cleaning and patients' daily care were the key steps to organising a practical ICU ward during the COVID-19 pandemic.
Xiangfeng Li

EP08-171-21-Trend analysis of exponential increase of COVID-19 cases in PakistanThe study was conducted to see the trends of COVID-19 among the Pakistani population. Pakistan started to feel the impact of the outbreak in mid-March with an increase in the number of cases at an alarming pace. So far, Sindh and Punjab province are the worst hit provinces with wide-spread community transmission.
Nadia Noreen

EP08-172-21-Sustaining TB services during the COVID-19 pandemic: experience and lessons learned from Nigeria in 2020Measures put in place to control the COVID-19 pandemic had the potential for interrupting tuberculosis (TB) services and erasing the gain made in TB control. Sustaining TB programmes during the COVID-19 pandemic became a priority of the national TB programme in Nigeria and the steps taken are documented and described in this study. 
Fadare Amos Omoniyi

EP08-175-21-Psychological experiences of mobile van TB screening team during COVID- 19 pandemic in Blantyre, MalawiResults have shown that health workers, working under MDU, experience several psychological challenges in this era of the COVID-19 pandemic and have compromised TB screening services. Therefore, mental health interventions are needed to mitigate these challenges. Self-coping style and psychological growth are important for health workers to maintain mental health.
Khwima Esther Mkalira

Speakers
Mahfuza Rifat
BRAC
star star star star star
Cosmas Mwashumbe
County Government of Mombasa
star star star star star
Nadia Noreen
Directorate of Central Health Establishments
star star star star star
Fadare Amos Omoniyi
World Health Organization
star star star star star
Khwima Esther Mkalira
Mobile Van TB coordinator
Ministry of Health
star star star star star
E-posters
EP03-Digital technology in the fight against TB
event_note Wednesday, 21 Oct 2020
query_builder 10:00 - 11:00 | Event time (GMT+2)
query_builder 10:00 - 11:00 | Your time (GMT)
place Online Session/Virtual
card_travel E-poster session
mic English
EP03-Digital technology in the fight against TB
*Please scroll down for more information*
These E-posters will be displayed from 10 am Central European Summer Time, on Wednesday 21 October for 24 hours.

EP03-118-21-Implementation of artificial intelligence for presumptive TB screening in Nagpur, IndiaIntroduction of newer technologies such as artificial intelligence in detection of diseases including tuberculosis (TB) are being piloted for efficacy and effectiveness. One such tool - qXR - was implemented for chest x-ray screening followed by microbiological testing for confirmation of TB. Lessons learned from the pilot can be used for scale-up.
Shibu Vijayan

EP03-119-21-Decentralised drug-resistant TB treatment challenges in South Africa and options for implementation of a smartphone application based on latest guidelinesSouth Africa has the third highest number of notified cases of drug- resistant tuberculosis. We discuss use of behaviour change theory to understand key barriers to awareness of, and access to, new care and treatment guidelines, as well as the development of a novel point-of-care decision supporting smart phone application.
Susanne Luedtke

EP03-120-21-Disease patterns on computer-assisted chest radiography in a community-based prevalence survey for TBCommunity-wide active case finding (ACF) for tuberculosis (TB) is a proposed intervention to reduce the burden of the disease. Computer-assisted radiography is an essential tool in the ACF intervention and can potentially be used to screen for undiagnosed, non-communicable diseases. We described the observations from a prevalence survey in communities in Blantyre.
Hussein Twabi

EP03-121-21-Integrated digital adherence technologies for TB: determinants of technology-derived adherenceThe Integrated Digital Adherence Technology Initiative (IDAT) enroled 12,100 patients in various technologies - 99DOTS (directly observed treatment, short course), MERM (medication event reminder monitor system, and video observed therapy (VOT) - across eight districts and three states in India. Heterogeneity in the outcome measure of technology-derived adherence is observed with various systems, technology and temporal and patient-level factors, affecting DAT uptake and engagement. 
Sirisha Papineni

EP03-122-21-Implementing a referral system for drug-resistant TB patients to maximise treatment linkages to the public sector and minimise the treatment initiation time in Mumbai, IndiaAchieving early elimination requires a strong referral mechanism where patient and private hospitals engage throughout the treatment. PATH is collaborating with the Mumbai Corporation to link privately diagnosed drug-resistant tuberculosis patients to the public sector. Effective referral mechanism and implementation strategy has resulted in successful patient linkages to the public sector.
Dnyaneshwar Waman

EP03-123-21-Methods for estimating spatial and time-varying transmission patterns of TB in Espirito Santo, Brazil, between 2005-2013Tuberculosis (TB) case notification data is often collected for surveillance. We describe a method to estimate reproductive numbers with spatial variability using this data. We correlate estimated reproductive numbers in four municipalities in Espirito Santo, Brazil, with data from a concurrent household contact study and RFLP to understand transmission dynamics.

Benjamin Rader

EP03-124-21-eHealth in the future of TB medicines management: a case of a TB medicines web-based ordering and reporting system in UgandaIn developing countries, healthcare systems face major challenges with tuberculosis (TB) medicines management and reporting. Electronic TB medicines ordering and reporting systems facilitate information gathering for healthcare decision support by enhancing the speed and accuracy of data transmission and better stock monitoring, thus ensuring uninterrupted medicine availability.
Hawa Nakato

EP03-125-21-How can we find TB patients not linked to care? Lessons learned from a systematic tracing process implemented in the Western Cape Province, South AfricaTuberculosis (TB) case finding and treatment initiation is a major challenge in the Western Cape, South Africa. Linkage to care has individual benefits and reduces risk of onward transmission. Patient case finding requires use of different strategies, creativity and flexibility. 
Nosivuyile Vanqa

EP03-126-21-An assessment of the effectiveness of mobile community-based TB screening in Blantyre, Thyolo and Mwanza, in MalawiMobile van intervention has proved to be a viable strategy in finding missing active tuberculosis (TB) cases. All cases have been referred to the nearest hospitals for treatment and proper management. Sustainability of this intervention within the National TB Control Programme will see Malawi achieving its goal of ending TB infection in the country.
Allan Chimpeni

EP03-127-21-Decentralising access to digital information management to treatment supporters level for efficient real-time patient managementTreatment supporters (TS) counsel and follow up with TB patients until treatment completion. With Nikshay, India’s TB patient management system, treatment supporters can log in and update a TB patient’s health record. On treatment completion, the TS' honorarium can be processed digitally without delay.
Manu Easow Mathew

Speakers
Manu Easow Mathew
National Consultant
World Health Organisation
star star star star star
Shibu Vijayan
PATH
star star star star star
Sirisha Papineni
World Health Partners
star star star star star
Susanne Luedtke
University College London
star star star star star
Hussein Twabi
Helse Nord Tuberculosis Initiative
star star star star star
Dnyaneshwar Waman
PATH
star star star star star
Benjamin Rader
PhD Candidate
Boston University School of Public Health
star star star star star
Hawa Nakato
Ministry of Health
star star star star star
Nosivuyile Vanqa
Stellenbosch University
star star star star star
Allan Chimpeni
Malawi National TB control Program
star star star star star
E-posters
EP09-Improved acceptability of TB regimens needed
event_note Wednesday, 21 Oct 2020
query_builder 10:00 - 11:00 | Event time (GMT+2)
query_builder 10:00 - 11:00 | Your time (GMT)
place Online Session/Virtual
card_travel E-poster session
mic English
EP09-Improved acceptability of TB regimens needed
*Please scroll down for more information*
These E-posters will be displayed from 10 am Central European Summer Time, on Wednesday 21 October for 24 hours.

EP09-176-21-Risk factors for cycloserine neurotoxicity in patients treated for multidrug-resistant TBCycloserine has been re-classified as a category B drug by the World Health Organization. The neurotoxicity associated with cylcoserine has limited its use in treatment programmes. We systemically collected neurotoxicity data in patients in Cape Town treated with cycloserine, dosed as terizidone, for multidrug-resistant TB. We then evaluated factors, including cycloserine AUC, with neurotoxicity.
Richard Court

EP09-177-21-Hearing loss on second line injectable therapy for rifampin-resistant TB in a retrospective cohort in Worcester, South AfricaSecond line injectables (SLIs) remain a part of the drug-resistant TB regimen in many settings globally, even with SLI-induced ototoxicity rates remaining high. In this South African rifampin-resistant TB cohort, regimen adjustments due to hearing loss were common, further emphasising the need for access to SLI-sparing regimens.
Tara C Bouton

EP09-178-21-Treatment outcome of shorter regimen for multidrug-resistant TB in Pakistan 2018The National Tuberculosis (TB) Programme in Pakistan recommended a shorter regimen of nine-11 months in January 2018 under programmatic settings in all PMDT sites of the country. We compared treatment outcome of patients who were put on the shorter regimen, with those who were eligible for the shorter regimen but who were put on the longer one.
Abdul Ghafoor

EP09-179-21-From pilot to nationwide scale-up of shorter treatment regimen for drug-resistant TB treatment: lessons from NigeriaFollowing the adoption and rapid scale-up of GeneXpert as a primary tuberculosis (TB) diagnostic tool, limited bed spaces resulted in the challenge of a huge number of diagnosed drug-resistant TB (DR-TB) patients on treatment waiting lists. The CTB project facilitated nationwide scale-up of STR and NDs, including establishing aDSM for newly diagnosed DR-TB patients.
Sani Useni

EP09-180-21-Preferences for shorter regimens and child-friendly formulations for TB preventive treatment among families affected by TB in Lima, PeruFocus group discussions with families affected by tuberculosis (TB) in Lima, Peru, explored preferences for TB preventive treatment regimens, for both adult and child contacts, and sought to understand the drivers behind these preferences.
Courtney Yuen

EP09-182-21-Safety and efficacy of allogeneic γδ T cells for multidrug-resistant TB: an interim analysis of a prospective single centre, open labeled, non-randomised, controlled matched trialAnti-tuberculosis (TB) drugs for multidrug-resistant (MDR-TB) and rifampicin-resistant TB (RR-TB) currently encounter many obstacles and host-directed therapy approaches are now a focus for use as adjunct treatment options for shortening duration, limiting immunopathology, and improving outcomes. The safety and efficacy of γδT cells have been studied in our pilot trial, which is the first one worldwide.
Liang Fu

EP09-183-21-Interim outcomes of bedaquiline-containing regimen for the treatment of MDR/XDR-TB — a prospective cohort study from Hunan, ChinaChina introduced bedaquiline relatively late and little data exists on its use outside clinical trials. We conducted  a prospective cohort study to evaluate the effectiveness and safety of bedaquiline-containing regimen for 24 weeks intensive treatment of multidrug-resistant tuberculosis and extensively drug-resistant tuberculosis (MDR/XDR-TB) in Hunan province, China.
li shi

EP09-184-21-Treatment interruption patterns among patients on bedaquiline- containing regimen under programmatic conditionsThis was an observational study, including 275 consecutively enrolled tuberculosis (TB) patients, who received a bedaquiline-containing regimen under the national TB programme in India. The study analysed the reasons for interruptions of treatment and loss to follow-up and their effect on interim treatment outcomes during the first six months of treatment.
Rupak Singla

EP09-185-21-Incidence rate of linezolid adverse events among Myanmar adult MDR/RR-TB patients on individualised longer drug-resistant TB regimensLinezolid, a Group A drug, has evidences for significant treatment success but it also has common, serious adverse events such as myelosuppression and peripheral neuropathy. The study determined the incidence rate of linezolid adverse events and characterised the safety of linezolid among Myanmar adult multidrug-resistant and rifampicin-resistant tuberculosis (TB) patients who were on individualised, longer drug-resistant TB regimens.
Thandar Hmun

EP09-186-21-Real-time payment of Nikshay Poshan Yojana under direct benefit transfer scheme improved overall notification, treatment adherence and outcome of TB and DR-TB patients in Odisha, IndiaReal-time payment of Nikshay Poshan Yojana under a direct benefit transfer scheme improved the overall notification, treatment adherence and outcome of tuberculosis (TB) and drug-resistant TB patients in Odisha, India. The National TB Programme performance rank in the Odisha state went up from 27th to 15th during 2019.
Gayadhar Mallick

Speakers
Tara C Bouton
Boston University School of Medicine
star star star star star
Courtney Yuen
Assistant Professor
Harvard Medical School
star star star star star
Gayadhar Mallick
The Union South East Asia
star star star star star
Richard Court
University of Cape Town
star star star star star
Abdul Ghafoor
National TB Programme
star star star star star
li shi
Changsha Central Hospital, affiliated to University of South China
star star star star star
Thandar Hmun
Ministry of Health and Sports
star star star star star
Liang Fu
Shenzhen Third People's Hospital
star star star star star
E-posters
EP04-Learning from epidemiological analyses
event_note Wednesday, 21 Oct 2020
query_builder 10:00 - 11:00 | Event time (GMT+2)
query_builder 10:00 - 11:00 | Your time (GMT)
place Online Session/Virtual
card_travel E-poster session
mic English
EP04-Learning from epidemiological analyses
*Please scroll down for more information*
These E-posters will be displayed from 10 am Central European Summer Time, on Wednesday 21 October for 24 hours.

EP04-128-21-Results of pulmonary TB screening for the elderly aged ≥ 65 years in Korea, 2019The KCDC selected six regions with a high tuberculosis (TB) incidence rate in the elderly, aged 65 years or over, and conducted TB screening. The project aims to early detect and treat elderly TB patients and prevent TB transmission among the elderly population. This paper describes the study results.
Heeae Kim

EP04-129-21-Excess mortality in TB patients diagnosed at hospital vs at primary healthcare in South AfricaInitial loss to follow-up among tuberculosis (TB) patients is a significant gap in the TB cascade and includes pre-treatment mortality. We evaluated all TB patients diagnosed at primary healthcare, district or tertiary hospitals in two sub-districts of Cape Town. We identified predictors of mortality and demonstrated the time to death using survival analyses.
Muhammad Osman

EP04-130-21-A geo-epidemiological approach to diagnose social inequities among territories vulnerable to TB in the North-East of BrazilIdentify the social inequalities associated with the occurrence of tuberculosis in areas at risk of the disease. This is an ecological study. For the analyses, the statistical model called Generalised Additive Models for Location, Scale and Shape, was used.
Ricardo Arcêncio

EP04-131-21-Poor linkage to care and high mortality among pregnant women with TB in South AfricaThis study describes linkage to care and mortality among pregnant women diagnosed with tuberculosis (TB) in Cape Town, South Africa. Using routinely collected TB data, we describe this cohort of pregnant women with TB, stratified by location of diagnosis and hospital vs. primary health care facility. 
Sue-Ann Meehan

EP04-132-21-Individual associated factors for developing tuberculous meningitis: a cross-sectional studyDiagnosis of tuberculous meningitis (TBM) is challenging. We analysed the data of demographics, comorbidities and concurrent tuberculosis (TB) for TBM and non-TBM in patients from January 2008 to December 2019 in Beijing Chest Hospital (Beijing, China). Individual associated factors for developing TBM were identified by using univariate and multivariate logistic regression.
Mailing Huang

EP04-133-21-Prevalence and risk factors of active TB in Chinese rheumatic patients: a multicentre, cross-sectional studyA tertiary, hospital-based and multicentre cross-sectional study was conducted between September 2014 and September 2015. Eligible patients with confirmed diagnosis of various rheumatic diseases were consecutively recruited and screened for active TB. Calculation of prevalence and analysis of risk factors along with data about demographic features, underlying diseases and past and current medications were obtained.
Xiaoqing Liu

EP04-134-21-Geospatial determinants of TB active case finding among men and working age adults in Lima, PeruIn screening programmes for tuberculosis (TB), men and working age adults often have lower participation. In an active case finding programme for TB in Lima, Peru, we aimed to identify locations that had higher than average attendance by men and working age adults.
Helen Jenkins

EP04-135-21-Geospatial mapping of TB burden in Anambra State, South-East NigeriaWe conducted a geospatial mapping of all the notified tuberculosis (TB) cases in the state to enable a visualisation of hotspots of TB transmission to be targeted with case finding interventions. Patterns of TB burden across the state showed marked differences in urban areas between local government areas in the state. 
Chukwuebuka Ugwu

EP04-136-21-Factors associated with health seeking behaviour of people to be evaluated for TB aged 15 years and above in Indonesia: tuberculosis prevalence surveyThis paper aims to examine the health seeking behaviour of people to be evaluated for tuberculosis (TB). This study included adults to be evaluated for TB aged 15 years old and above based on the Indonesia TB prevalence survey, within the initial behaviour model. 
Permata Silitonga

EP04-137-21-Seasonality and trend of TB incidence rate after GeneXpert MTB/RIF era: a study in a vulnerable region from Brazilian Eastern AmazonEcological study in Macapá, capital of the state of Amapá, region of the Brazilian Eastern Amazon. We applied the interrupted time series method for diagnosing seasonality and the Prais-Winsten method to classify the event trend.
Ricardo Arcêncio

EP04-138-21-TB incidence rates and their determinants: an ecological multicountry analysis, 2005-2015The study identified three intermediary social determinants of health that were associated with changes in tuberculosis (TB) incidence rates across 115 countries between 2005 and 2015. Further action to address these determinants may help to achieve global goals in TB incidence reduction by 2035.
Fiona Alma Koeltringer

EP04-139-21-Risk factors for mortality among patients with multidrug-resistant TB in Uganda: a case-control studyRisk factors for mortality among patients with multidrug-resistant tuberculosis (MDR-TB) in Uganda: a case-control study for patients in the 2016 cohort using the long MDR-TB treatment regimen. This was done under programmatic conditions. 
Enock Kizito

Speakers
Mailing Huang
Beijing Chest Hospital, Capital Medical University
star star star star star
Enock Kizito
MDR-TB Advisor
University Research Co. Kampala, Uganda
star star star star star
Helen Jenkins
Boston University School of Public Health
star star star star star
Ricardo Arcêncio
Nurse and professor
Ribeirão Preto College of Nursing at University of São Paulo
star star star star star
Heeae Kim
Korea Centers for Disease Control and Prevention (KCDC)
star star star star star
Muhammad Osman
Stellenbosch University, Desmond Tutu TB Centre
star star star star star
Sue-Ann Meehan
Senior Researcher
Stellenbosch University
star star star star star
Xiaoqing Liu
Peking Union Medical College Hospital
star star star star star
Permata Silitonga
Duke Kunshan University
star star star star star
Fiona Alma Koeltringer
Medical Doctor
Karolinska Insitutet
star star star star star
Chukwuebuka Ugwu
World Health Organization
star star star star star
E-posters
EP01-Resisting the resistance
event_note Wednesday, 21 Oct 2020
query_builder 10:00 - 11:00 | Event time (GMT+2)
query_builder 10:00 - 11:00 | Your time (GMT)
place Online Session/Virtual
card_travel E-poster session
mic English
EP01-Resisting the resistance
*Please scroll down for more information*
These E-posters will be displayed from 10 am Central European Summer Time, on Wednesday 21 October for 24 hours.

EP01-100-21-Pharmacokinetics of anti-TB drugs in multidrug-resistant TB patients in IndiaA pharmacokinetic (PK) study of drugs used to treat multidrug-resistant (MDR) tuberculosis (TB) was undertaken in 350 adult MDR-TB patients treated according to the prevailing guidelines in India. Factors influencing drug PK and end of intensive phase status were also determined. Results of this study will be discussed.
Agibothu Kupparam Hemanth Kumar

EP01-101-21-Multidrug-resistant TB and its determinants of health service, community and social context in the state of São Paulo, BrazilThis study presents the social determinants of health in relation to the occurrence of multidrug-resistant tuberculosis, key information for disease control in regions with great social inequity. We emphasise the importance of socioeconomic, demographic and health system structure conditions for the spread of the disease.
Ricardo Arcêncio

EP01-102-21-Decentralised care for rifampicin-resistant TB in Western Cape, South Africa: a laboratory cohort studySouth Africa implemented a policy to decentralise rifampicin-resistant tuberculosis (RR-TB) care in 2011. We used laboratory data from the Western Cape province to assess patterns of RR-TB care and identify changes in hospitalisation rates, length of hospital stay and travel burden from 2012-2014. We compared Cape Town with more rural districts.
Helen Jenkins

EP01-103-21-Effectiveness, safety and feasibility of nine-month treatment regimen for rifampin-resistant TB in the PhilippinesThe short nine-month multidrug-resistant tuberculosis regimen had a high treatment success rate (74 percent) with a favourable safety profile in a prospective single-arm study conducted in the Philippines during 07/2015-12/2016. Nine-month treatment regimen operational research had a major impact on building national capacity and infrastructure for programmatic adoption of the new regimen in country.
Vivian Lofranco

EP01-104-21-Characterising multidrug-resistant tuberculosis transmission in rural KwaZulu-Natal: a prospective cohort studyThis study combined whole genome sequencing of 129 Mycobacterium tuberculosis (Mtb) isolates with demographic data from patients with multidrug-resistant TB in KwaZulu-Natal, South Africa. Transmission clusters based on genomic differences were identified. Relationships between demographic characteristics, Mtb lineage, rpoB mutation and transmission clustering were examined, aiming to elucidate drivers of Mtb transmission.
Cassandra Fairhead

EP01-105-21-Effectiveness and safety of use of bedaquiline and delamanid in combination for drug-resistant extrapulmonary TB in Mumbai, IndiaMédecins Sans Frontières has been providing treatment, including bedaquiline and/or delamanid, to patients with drug-resistant tuberculosis (TB) in Mumbai since 2015. Cases are referred with complex resistance profiles and extensive treatment history. This study aims to describe the effectiveness and safety of use of bedaquiline and delamanid for drug-resistant extrapulmonary TB.
Himani Mongia

EP01-106-21-Eliciting patient preferences for different attributes of a community-based model for management of multidrug-resistant TB in Uganda: a discrete choice experimentThe advent of all-oral regimens for the management of multidrug- resistant tuberculosis makes the implementation of home-based treatment a possibility for this group of patients. However, to be successful, options for home-based care should take into consideration patient preferences for different aspects of care.    
Stella Zawedde-Muyanja

EP01-107-21-Treatment of multidrug-resistant TB with modified shorter all-oral treatment regimen: Belarus operational research studyIn October 2018, Belarus started to use mSTR for multidrug-resistant tuberculosis under operational research conditions. By 1st May 2020, 415 patients were included in the study and, of them, 114 had final treatment outcomes with encouraging results (89% of treatment success).
Alena Skrahina

EP01-108-21-Patient’s perspective on drug-resistant TB medication: does it matter? Putting research into action to develop information, education and communication materialA qualitative study of drug-resistant tuberculosis (DR-TB) treatment from the perspective and experience of patient, family, healthcare worker and psychologist in six health facilities within three districts of Indonesia as a basis for developing DR-TB information, education and communication material based on the Health Belief Model and Transtheoretical Model.
Ferdiana Yunita

EP01-109-21-The role of clinical healthcare champions in driving drug-resistant TB policy implementation in South AfricaIn South Africa, champions have emerged as a driving force behind the implementation of decentralised management of drug-resistant tuberculosis (DR-TB). This study explored the typology of champions in the decentralisation of DR-TB management, strategies that champions used to implement policy and the contextual factors that enabled or hindered their agency.
Sacha Le Roux

Speakers
Alena Skrahina
The Republican Scientific and Practical Center for Pulmonology and TB
star star star star star
Agibothu Kupparam Hemanth Kumar
ICMR - National Institute for Research in Tuberculosis
star star star star star
Ferdiana Yunita
Lecturer, Researcher, Public health practitioner-TB
USAID funded project Challenge TB
star star star star star
Sacha Le Roux
University of Cape Town
star star star star star
Stella Zawedde-Muyanja
INFECTIOUS DISEASES INSTITUTE
star star star star star
E-posters
EPTBS-TBScience 2020 - E-posters - Displayed All Conference Days
event_note Wednesday, 21 Oct 2020
query_builder 10:00 - 11:00 | Event time (GMT+2)
query_builder 10:00 - 11:00 | Your time (GMT)
place Online Session/Virtual
card_travel E-poster session
mic English
EPTBS-TBScience 2020 - E-posters - Displayed All Conference Days
*Please scroll down for more information*
All TBScience 2020 E-posters will be displayed from 10 am Central European Summer Time (CEST), on Wednesday, 21 October for the duration of the conference and beyond

EP-TBS-01-Increased neutrophil count and decreased neutrophil CD15 expression correlate with TB disease severity and treatment response
Lerato Ndlovu

EP-TBS-02-Genome-wide identification of Mycobacterium tuberculosis genetic markers associated with the history of BCG vaccination
Kamela Charmaine S. Ng

EP-TBS-03-Characterization of regulatory B-cells for tuberculosis management
Irene Latorre

EP-TBS-04-Different antimycobacterial activity of alveolar macrophages in various lung legions of tuberculosis patients
Sergey Skornyakov

EP-TBS-05-Plasma mediators of phagocytosis in tuberculosis patients during anti-TB treatment and zinc supplementation
Victory Edem

EP-TBS-06-Discerning divergent tuberculosis endotypes: A meta-analysis of individual patient data
Andrew DiNardo

EP-TBS-07-Plasma Interferon (IFN)-g Inducible Protein 10 (IP-10) levels but not the QuantiFERON Gold plus assay correlate with disease severity and paradoxical reactions in extrapulmonary tuberculosis
Isabelle Suarez

EP-TBS-08-Host immune factors related to non-multidrug resistant tuberculosis with treatment history in Vietnam
Naoto Keicho

EP-TBS-09-Risk factors for the development of tuberculosis in children with chronic non-specific lung diseases.
Sofya Nakonechnaya

EP-TBS-10-Polyfunctional T-cells and IL-2 production decrease during pregnancy in women with latent TB infection
Jyoti Mathad

EP-TBS-11-Neutrophils Contribute to Tuberculosis-linked Inflammation and lung pathology
Caleb Nwongbouwoh Muefong

EP-TBS-12-Association of neutrophil-derived inflammatory mediator levels with lung pathology in active tuberculosis at diagnosis
Caleb Nwongbouwoh Muefong

EP-TBS-13-Characterising the BCG-induced antibody response for antigen discovery
Rachel Tanner

EP-TBS-14-ESAT-6 / CFP-10-stimulated metabolic activity of pleural fluid cells if cured tuberculosis or TB / HIV
Sergey Skornyakov

EP-TBS-15-Blood-Based Biomarkers of Tuberculosis in Children Integrating Metabolomic and Transcriptomic Data
Jeffrey A Tornheim

EP-TBS-16-Identification of TGF-β1 in pleural tuberculosis: the possible role in fibrosis
Silvio Renan Pinheiro Victor de Araújo

EP-TBS-17-Analysis of serum microRNAs as pulmonary tuberculosis biomarkers
JaeIn Jung

EP-TBS-18-Up-regulated programmed death protein 1 expression on CD4 T cells in patients with MDR-TB  associated with lung lesion and mycobacterial load
Qi Tan

EP-TBS-19-Malnutrition affects levels of vascular endothelial growth factor levels among children and adolescents with pulmonary tuberculosis?
Caio Pluvier Duarte Costa

EP-TBS-20-Towards identification of protein markers of Mycobacterium tuberculosis H37Rv extracellular vesicles (EV)
MEHALENE JAYARAM

EP-TBS-21-Increased frequency of CD39+ regulatory T cells in the pleural fluid of patients with Tuberculosisin comparison to other exudative causes
Ana Paula Santos

EP-TBS-22-Longitudinal analysis of M. tuberculosis-specific T cell responses demonstrates dynamic T cell responses to ESAT-6 and CFP-10 during pregnancy independently of mitogen responses.
Aparajita Saha

EP-TBS-23-Serum Cytokine Profile as Biomarker for Multi-drug Resistant Tuberculosis
Alahaman Nana Boakye

EP-TBS-24-Reanalysis and validation of Tuberculosis genes signature in blood and pleural fluid from patients with exudative pleural effusion
Raquel da Silva Corrêa

EP-TBS-25-TimBre, Cough based screening of Pulmonary Tuberculosis using Machine Learning that is Explainable and Interpretable
Rahul Pathri

EP-TBS-26-HbA1C as prognostic factor in PTB
Sarang Patil

EP-TBS-27-Better intradermal delivery for bacille Calmette-Guérin (BCG) vaccine by microneedles in healthy adults of S. Korea
Hyejon Lee

EP-TBS-28-MULTIPLEX BIOMARKER ASSAY FOR DETECTION OF MYCOBACTERIUM TUBERCULOSIS
Puneet Gupta

EP-TBS-29-Role of the chemokine receptor CXCR3 in the recruitment and retention of lung resident memory T cells following a pulmonary TB vaccine. 
Warwick Britton

EP-TBS-31-Benefit of Quantiferon-TB Gold plus in incidence of TB disease in Heath care workers of Central Chest Institute of Thailand
piamlarp sangsayunh

EP-TBS-32-The blood monocyte/lymphocyte, neutrophil/lymphocyte and platelet/lymphocyte ratios in children with pulmonary tuberculosis
Larissa Gorbach

EP-TBS-33-Pulmonary tuberculosis patients have an anaerobe-enriched microbiota associated with a pro-inflammatory peripheral host immune phenotype
Charissa Naidoo

EP-TBS-34-The epidemiologic impact and cost-effectiveness of new tuberculosis vaccines on rifampicin resistant and multidrug resistant tuberculosis in India and China
Chathika Weerasuriya

EP-TBS-36-Novel, culture-free, same-day TB diagnosis with ultrasensitive ELISA
Rikiya Takeuchi

EP-TBS-37-Tuberculosis screening in point-of-care settings: Proof-of-concept for a fast and easy sample-to-answer qPCR-based protocol
Alexandre Dias Tavares Costa

EP-TBS-38-Diagnostic accuracy of three urine lipoarabinomannan tuberculosis assays in HIV-negative outpatients
Tobias Broger

EP-TBS-39-To Study The Presence Of Live Mycobacterium Tuberculosis In Resected Lung Specimens Of Patients Undergoing Lung resection Surgery For Post-Tuberculosis Sequelae
Pallavi Purwar

EP-TBS-40-What can tuberculosis prevalence surveys tell us about the duration of asymptomatic bacteriologically-positive disease?
Chu-Chang Ku

EP-TBS-41-An RNA signature for tuberculosis risk in pregnant women: a prospective cohort study from India
Jyoti Mathad

EP-TBS-42-Analysis of mycobacterial trans-renal DNA for the diagnosis of Tuberculous Meningitis in adults.
Manisha Dass

EP-TBS-43-Developing a tool to identify and screen Latent Tuberculosis Infection (LTBI) with likelihood of progression to active Tuberculosis (ATB)
Prashant Singh

EP-TBS-44-QuantiFERON TB plus-negative results in clinically diagnosed paediatric tuberculosis: immune suppression or misdiagnosis?
Gloria Ivy Mensah

EP-TBS-45-Evaluation of a blood-based antigen test for tuberculosis in HIV-exposed children younger than 5 years
Tony Hu

EP-TBS-46-Adverse drug reactions in MDR TB Patients on ATT
Sarang Patil

EP-TBS-47-Species and Drug Susceptibility profile of Non-tuberculous Mycobacteria isolated from presumptive TB cases
PRIYA RAJENDRAN

EP-TBS-48-MAMA-PCR assay for the detection of point mutations associated with drug resistance in Mycobacterium tuberculosis clinical isolates
Raquel Muñiz-Salazar

EP-TBS-49-Genomic diversity in Mycobacterium tuberculosis from human lung resections reveals a high degree of multiclonal infections in a high-burden MDR-TB setting
Miguel Moreno-Molina

EP-TBS-50-Pathogen genome sequencing to guide treatment regimen designs for multidrug-resistant tuberculosis
Hans-Peter Grobbel

EP-TBS-51-An evolutionary functional genomics approach identifies novel candidate regions involved in isoniazid resistance in Mycobacterium tuberculosis
Victoria Furió

EP-TBS-52-Antibiotic Resistance Profile Determination Using Whole Genome Sequencing
Ryan Howard

EP-TBS-53-Rapid genomic drug resistance prediction from clinical Mycobacterium tuberculosis specimens using amplicon based deep sequencing based on Deeplex-MycTB
Stefan Niemann

EP-TBS-54-Multi-resistant tuberculosis and HIV infection in Kinshasa: 2011-2018. DRC “Epidemiological, clinical and therapeutic aspects”
Nicole ANSHAMBI

EP-TBS-55-Long Read DNA Sequencing of XDR/MDR Tuberculosis Samples to Investigate Factors Leading to Resistance and Virulence
Michael Harris

EP-TBS-56-Genome-wide detection of epistasis in antibiotic resistant M. tuberculosis
Anna Green

EP-TBS-57-Population structure, biogeography and transmissibility of Mycobacterium tuberculosis
Luca Freschi

EP-TBS-58-Safety and Efficacy of an MDR-TB All-oral Short-course Regimen in China: An Preliminary Analysis of the MDR-Chi clinical trial
Liang Fu

EP-TBS-59-Drug exposure and minimum inhibitory concentration predict pulmonary tuberculosis treatment response
Xubin Zheng

EP-TBS-60-A novel therapeutic vaccine against multi-drug resistant tuberculosis by T cell-immunity in phase 1 clinical trial.
Masaji Okada

EP-TBS-61-Improving the safety of TB therapy with novel diagnostic biomarkers of liver toxicity – a study in UK and Ugandan patients
Derek Sloan

EP-TBS-62-Tuberculosis meningitis mouse model
Tuhina Gupta

EP-TBS-63-Pharmacokinetics of the three-drug fixed-dose dispersible tablet in children
Aziza Pakhlavonova

EP-TBS-64-Does BCG Vaccination protect against infection with Mycobacterium tuberculosis in Vietnamese schoolchildren?
Puck Pelzer

EP-TBS-65-Time to positivity as a surrogate biomarker of time to culture conversion
Belén P. Solans

EP-TBS-66-Use of the contact management register to identify those with Active and Latent TB, Kenya, Jan-March 2020
RHODA POLA

EP-TBS-67-Predicting Efficacy Outcome of Nine Tuberculosis Drugs in Phase 2a First-in-patients Studies
Nan Zhang

EP-TBS-69-Predicting optimal treatment durations for tuberculosis patients: a risk stratification algorithm and clinical simulation tool
Marjorie Imperial

EP-TBS-70-Adverse Drug Reactions in MDR TB Patients on Category IV Regimen in Western Odisha
SUMAN KUMAR JAGATY

EP-TBS-71-The effect of antiretroviral therapy and preventive tuberculosis therapy with anti-TB drugs on the duration of TB remission in HIV-infected patients
Igor Medvinskiy

EP-TBS-72-A Urine Colorimetric Assay for Levofloxacin Concentrations and Optimized Regimen Development
Prakruti Rao

EP-TBS-73-Development and Application of an Integrated Biomarker - Clinical Endpoint Tool for Late Stage TB Regimen Development and Clinical Trial Design
Marjorie Imperial

EP-TBS-74-Leveraging Neural Networks and Imaging Experts in Loops for Automated Tuberculosis Screening Using Chest Radiographs in Population Screening Programs to ensure efficient workflows.
Amit Kharat

EP-TBS-75-A model for the integration of traditional medicine into conventional medicine for the treatment of Tuberculosis (TB) in Zimbabwe
Winnet Enerita Chipato

EP-TBS-76-Point-of-Care Saliva Assay for Levofloxacin Concentrations and Personalized Dosing in Patients with Multidrug-Resistant Tuberculosis in Tanzania
Sagal Mohamed

EP-TBS-77-PBPK Model Informed Prediction to Evaluate the Effect of Renal Impairment and OCT genotypes on the Ethambutol Disposition
Yumi Park

EP-TBS-78-Development of Population Pharmacokinetic Model of the First-line anti-TB drugs in Korean patients with TB for Therapeutic Drug Monitoring Guided Dose Adjustment
Yumi Park

EP-TBS-79-Model Informed Personalized Dosing Algorithm Development for TB Therapy in Center for Personalized Precision Medicine (cPMTb)
Yumi Park

EP-TBS-80-Classifying adherence trajectories: an innovative tool for regimen development
Stephanie Law

EP-TBS-81-Predicting pretomanid penetration into patient lesions of tuberculosis
Jacqueline Ernest

EP-TBS-82-Rifapentine pharmacokinetics and pharmacodynamics: murine and human models to identify optimal dosing for treatment of latent M. tuberculosis infection
Jacqueline Ernest

EP-TBS-83-SLCO1B1 and SLC10A1 polymorphism and plasma rifampin concentrations in patients with co-morbidity tuberculosis-diabetes mellitus in Baja California, Mexico
Ricardo Perea-Jacobo

EP-TBS-84-Individual-Level Data Meta-Analysis of Adverse Events from Clinical Trials of Drug Sensitive Tuberculosis Treatment Regimens
Leah Jarlsberg

EP-TBS-85-G-clamp-inspired ligands and their effects on G-quadruplexes from Mycobacterium tuberculosis
Egor Shitikov

EP-TBS-86-Prediction of early bacterial activity (EBA) of bedaquiline in tuberculosis
Federico Romano

Speakers
Jeffrey A Tornheim
Johns Hopkins University School of Medicine, Division of Infectious Diseases
star star star star star
Rachel Tanner
University of Oxford
star star star star star
Luca Freschi
Post-doctoral fellow
Harvard Medical School
star star star star star
Egor Shitikov
Research and Clinical Center for Physical Chemical Medicine
star star star star star
JaeIn Jung
Korea National Institute of Health, Korea Centers for Disease Control and Prevention
star star star star star
Sarang Patil
D.Y Patil Hospital, Mumbai
star star star star star
Puck Pelzer
Epidemiologist
KNCV Tuberculosis foundation
star star star star star
Federico Romano
UCL
star star star star star
Larissa Gorbach
Scientific Secretary
Public Institution “Republican Scientific and Practical Centre “Mother and Child”
star star star star star
Ana Paula Santos
UERJ
star star star star star
piamlarp sangsayunh
Central Chest institute of Thailand
star star star star star
Stefan Niemann
Research Center Borstel
star star star star star
Pallavi Purwar
Thoracic Surgeon
National Institute of Tuberculosis and Respiratory Diseases
star star star star star
Hans-Peter Grobbel
Research Center Borstel, Clinical Infectious Diseases
star star star star star
Hyejon Lee
International Tuberculosis Research Center
star star star star star
Rikiya Takeuchi
R&D Department, TAUNS Laboratories, Inc.
star star star star star
Xubin Zheng
Fudan University
star star star star star
Belén P. Solans
Postdoc researcher
University of California San Francisco
star star star star star
Jyoti Mathad
Weill Cornell Medical College
star star star star star
Aparajita Saha
Department of Medicine, University of Washington
star star star star star
Chu-Chang Ku
Research associate
School of Health and Related Research, University of Sheffield
star star star star star
RHODA POLA
National TB Program
star star star star star
Yumi Park
Inje University College of Medicine
star star star star star
PRIYA RAJENDRAN
ICMR NATIONAL INSTITUTE FOR RESEARCH IN TUBERCULOSIS
star star star star star
Victoria Furió
Institute of Biomedicine of Valencia (IBV-CSIC)
star star star star star
Nicole ANSHAMBI
National Tuberculosis Program DRC
star star star star star
Nan Zhang
University of California, San Francisco
star star star star star
Gloria Ivy Mensah
Noguchi Memorial Institute
star star star star star
Irene Latorre
Postdoctoral researcher
Institut d’Investigació Germans Trias i Pujol
star star star star star
Puneet Gupta
NextGen Invitro Diagnostics Pvt Ltd
star star star star star
Charissa Naidoo
Stellenbosch University
star star star star star
Marjorie Imperial
University of California, San Francisco
star star star star star
Amit Kharat
Co-Founder
Deeptek Inc
star star star star star
Alexandre Dias Tavares Costa
Carlos Chagas Institute / Oswaldo Cruz Foundation (FIOCRUZ)
star star star star star
Manisha Dass
PGIMER (Post Graduation Institute of Medical Education and Research)
star star star star star
Michael Harris
NIAID / NIH
star star star star star
Masaji Okada
National Hospital Organization Kinki-chuo Chest Medical Center
star star star star star
SUMAN KUMAR JAGATY
SHANTI MEMORIAL HOSPITAL
star star star star star
Igor Medvinskiy
National Medical Research Center for Phthisiopulmonology and Infectious Diseases
star star star star star
Victory Edem
University of Ibadan
star star star star star
Qi Tan
Research Fellow
Department of Global Health and Social Medicine, Harvard Medical School, USA
star star star star star
Alahaman Nana Boakye
Department of Animal Biology and Conservation Science, University of Ghana
star star star star star
Raquel Muñiz-Salazar
Universidad Autónoma de Baja California
star star star star star
Prakruti Rao
University of Virginia
star star star star star
Sergey Skornyakov
National Medical Research Center of Tuberculosis and Infectious Diseases of Ministry of Health of the Russian Federation, Ural Research Institut
star star star star star
Andrew DiNardo
Baylor College of Medicine
star star star star star
Warwick Britton
Professor, Head TB Research Program
Centenary Institute
star star star star star
Prashant Singh
Co-founder
Celleome Biosciences LLP
star star star star star
Derek Sloan
Senior Clinical Lecturer
University of St Andrews
star star star star star
Isabelle Suarez
University Hospital of Cologne
star star star star star
Caio Pluvier Duarte Costa
Medical Student
Universidade Federal Fluminense
star star star star star
Sagal Mohamed
University of Virginia
star star star star star
Lerato Ndlovu
Africa Health Research Institute
star star star star star
Naoto Keicho
The Research Institute of Tuberculosis, JATA
star star star star star
Chathika Weerasuriya
London School of Hygiene and Tropical Medicine
star star star star star
Ryan Howard
Associate Scientist
MRIGlobal
star star star star star
Stephanie Law
Harvard Medical School
star star star star star
Liang Fu
Shenzhen Third People's Hospital
star star star star star
Caleb Nwongbouwoh Muefong
MRC Unit The Gambia at LSHTM
star star star star star
Tony Hu
Tulane University
star star star star star
Anna Green
Postdoctoral Fellow
Harvard Medical School
star star star star star
Tuhina Gupta
Assistant Research Scientist
University of Georgia
star star star star star
Jacqueline Ernest
PhD candidate
University of California, San Francisco
star star star star star
Tobias Broger
Heidelberg University Hospital
star star star star star
Miguel Moreno-Molina
Biomedicine Institute of Valencia
star star star star star
Ricardo Perea-Jacobo
Universidad Autónoma de Baja California
star star star star star
Kamela Charmaine S. Ng
Postdoctoral Researcher
Harvard Medical School
star star star star star
MEHALENE JAYARAM
UNIVERSITI SAINS MALAYSIA
star star star star star
Rahul Pathri
Founder
Docturnal Private Limited
star star star star star
Aziza Pakhlavonova
National Medical Research Center of Phthisiopulmonology and Infectious Diseases
star star star star star
Leah Jarlsberg
University of California San Francisco
star star star star star
Processing. Please wait.
Loading...